Photo of John Katko
R United States House · District 24 · New York

Rep. John Katko

Compare
Total votes
958
all sessions
Attendance
99%
14 missed
Near the chamber average
With party
81%
of cast votes
Lower than 97% of chamber peers
Bipartisan score
9%
crosses aisle rarely
Higher than 96% of chamber peers
Sponsored
474
bills & resolutions
Near the chamber average
Committees
0
assignments
474 bills and resolutions

Sponsored bills

Total
474
Primary
32
Co-sponsor
442
This page
474
matching current filters
Co-sponsor HR 5683
In committee · United States House · Co-sponsor
Department of Homeland Security Border Support Services Contracts Review Act

Department of Homeland Security Border Support Services Contracts Review Act This bill directs the Management Directorate of the Department of Homeland Security (DHS) to assess certain active contracts for services related to security along the land border with Mexico awarded in FY2021 or earlier. Specifically, this applies to any contract with a total value of $50 million or more, inclusive of contract options, relating to the procurement of services for DHS with respect to that border. The assessment must include a strategy to enhance coordination, minimize overlap, and increase cost-effectiveness among such contracts.

In committee Jan 21, 2022 1 co-sponsor
Co-sponsor HR 6232
In committee · United States House · Co-sponsor
To delay the implementation of a rule relating to the importation of sheep and goats and products derived from sheep and goats, and for other purposes.

This bill requires the Department of Agriculture (USDA) to submit a report on the potential costs and benefits of its proposed rule governing the importation of live sheep, goats, other ruminants, and products derived from sheep and goats. It also bars USDA from finalizing, implementing, administering, or enforcing the rule until one year after the date that USDA submits the report.

In committee Jan 4, 2022 1 co-sponsor
Co-sponsor HR 6000
In committee · United States House · Co-sponsor
Cures 2.0 Act

Cures 2.0 Act This bill addresses pandemic preparedness and public health issues, caregiver and patient engagement, drug development, insurance coverage, and biomedical research. The Department of Health and Human Services (HHS) must undertake research and other activities concerning COVID-19 and develop a strategy for future pandemics and declared emergencies. Additionally, the bill specifies actions to combat antimicrobial resistance. HHS may award grants for caregiver training. The bill also addresses diversity in clinical trials, collecting patient experience data during clinical trials, and coverage for care related to participation in specified clinical trials. The bill modifies the timeframe and requires additional guidance relating to expedited approval of certain breakthrough drugs, devices, or products. It also establishes two intercenter institutes within the Food and Drug Administration (FDA) focused on particular diseases that meet specified criteria. The bill also addresses (1) coverage in Medicare, Medicaid, and the Children's Health Insurance Program for telehealth, genetic and genomic testing, and other services; (2) electronic prescribing standards for Medicare drug benefits; and (3) access to Medicare and Medicaid claims data by certain registries. Furthermore, the bill prohibits the use of geographic tracking or biometrics in Medicaid electronic visit verification systems. The bill establishes the Advanced Research Projects Agency for Health (ARPA-H) within the National Institutes of Health to accelerate biomedical research and innovation through grants, contracts, cash prizes, and other means. The FDA may work with ARPA-H to expedite the development of medical products through specified activities.

In committee Jan 4, 2022 1 co-sponsor
Co-sponsor HR 3537
Signed into law · United States House · Co-sponsor
Accelerating Access to Critical Therapies for ALS Act

Accelerating Access to Critical Therapies for ALS Act This bill establishes grant programs to address neurodegenerative diseases, such as amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease), and contains other related provisions. The Department of Health and Human Services (HHS) shall award grants to eligible entities for scientific research utilizing data from expanded access to investigational ALS treatments for individuals who are not otherwise eligible for clinical trials.  The Food and Drug Administration (FDA) shall award grants to public and private entities to cover the costs of research and development of drugs that diagnose or treat ALS and other rare neurodegenerative diseases. HHS shall also establish the Public-Private Partnership for Neurodegenerative Diseases between the National Institutes of Health, the FDA, and at least one eligible entity (generally, an institution of higher education or a nonprofit organization). The partnership shall support the development and regulatory review of drugs that address ALS and other rare neurodegenerative diseases. The FDA shall publish on its website a five-year action plan for fostering the development of drugs that improve or extend the lives of people living with rare neurodegenerative diseases. The Government Accountability Office must report to Congress about the grants provided under this bill, including an analysis of the impact of such grants on research and development of treatments for ALS.

Signed into law Dec 23, 2021 1 co-sponsor
Co-sponsor HCONRES 65
In committee · United States House · Co-sponsor
Expressing the sense of the Congress that tax-exempt fraternal benefit societies have historically provided and continue to provide critical benefits to the people and communities of the United States.

This concurrent resolution expresses the sense of Congress that tax-exempt fraternal benefit societies provide critical benefits to the people and communities of the United States and their work should continue to be promoted.

In committee Dec 16, 2021 1 co-sponsor
Co-sponsor HR 5142
Signed into law · United States House · Co-sponsor
To award posthumously a Congressional Gold Medal, in commemoration to the servicemembers who perished in Afghanistan on August 26, 2021, during the evacuation of citizens of the United States and Afghan allies at Hamid Karzai International Airport, and for other purposes.

This bill posthumously provides for the award of a Congressional Gold Medal in commemoration of the 13 service members who died on August 26, 2021, while stationed at Hamid Karzai International Airport in Afghanistan.

Signed into law Dec 16, 2021 1 co-sponsor
Co-sponsor HR 6207
In committee · United States House · Co-sponsor
Humane Cosmetics Act of 2021

Humane Cosmetics Act of 2021 This bill generally prohibits animal testing in the evaluation of cosmetic products, and it prohibits the sale or transport of cosmetics developed using animal testing, subject to civil penalties. These prohibitions begin one year after enactment. The bill specifies exceptions to these prohibitions, including if such animal testing (1) is conducted outside the United States to comply with a foreign regulatory authority; (2) is pursuant to a specified finding that there are no nonanimal alternatives to test the safety of a potentially dangerous cosmetic product or ingredient; (3) is of a product or ingredient for a drug or device subject to regulation by the Food and Drug Administration (FDA); or (4) is required for a noncosmetic purpose pursuant to a state, federal, or foreign regulatory authority. Further, no animal-testing evidence may be used to establish the safety of a cosmetic product or ingredient that is regulated by the FDA after the effective date of this bill, subject to limited exceptions.

In committee Dec 10, 2021 1 co-sponsor
Co-sponsor HR 6223
In committee · United States House · Co-sponsor
BASE Act

Border Agents Stay Employed Act or the BASE Act This bill prohibits using federal funds to require any U.S. Customs and Border Protection officer or employee to receive a COVID-19 vaccine.

In committee Dec 10, 2021 1 co-sponsor
Co-sponsor HRES 317
Passed · United States House · Co-sponsor
Condemning the ongoing genocide and crimes against humanity being committed against Uyghurs and members of other religious and ethnic minority groups by the People’s Republic of China.

This resolution states that the Chinese government is responsible for ongoing abuses against the Uyghurs and other ethnic and religious minority groups and that these abuses constitute genocide and crimes against humanity. The resolution also condemns such genocide and crimes against humanity and calls on the President to take certain actions to put an end to these atrocities.

Passed Dec 8, 2021 1 co-sponsor
Co-sponsor HR 6192
In committee · United States House · Co-sponsor
High Rise Fire Sprinkler Incentive Act of 2021

High Rise Fire Sprinkler Incentive Act of 2021 This bill classifies any automatic fire sprinkler system retrofit property as 15-year property for purposes of accelerated depreciation.

In committee Dec 8, 2021 1 co-sponsor
Showing 171 to 180 of 474 bills
Previous 1 … 17 18 19 … 48 Next